PhD Scholarships Program
PhD scholarships co-funded by the Leukaemia Foundation and the Haematology Society of Australia and New Zealand (HSANZ).
The Leukaemia Foundation is helping more medical and science graduates pursue a research career in blood cancer by combining resources and working in partnership with HSANZ to co-fund PhD scholarships.
These prestigious doctoral scholarships are awarded to Australian applicants who demonstrate outstanding merit in blood cancer research. They are open to all areas of Australian research in blood cancers and blood cancer related disorders.
Applicants’ work must align with a least one of the Leukaemia Foundation’s seven research priorities:
1. Understanding the biology of blood cancers.
2. Precision medicine – investing in new, tailor-made therapies to treat each patient’s cancer.
3. New diagnostics.
4. Novel (new) therapies.
5. Psychosocial aspects of cancer.
6. Innovative clinical trials and/or incorporation of real world data.
7. Prevention research including investigating risk factors and possible causes of blood cancers.
The PhD scholarship program offers applicants – early career scientists, nurses and haematologists – a three-year scholarship with annual funding of $40,000 (a total of $120,000 per scholarship).
Three PhD scholarships will be granted in the first and second year of this program (2018 & 2019) and two scholarships in the third year (2020).
The total value of all eight scholarships is $960,000.
The HSANZ has an existing grants and awards program and its review process, expertise and selection panel will administer the PhD scholarship program – scholarship selection (with representation from the Leukaemia Foundation) and grants administration.
The selection criteria used by the HSANZ is based on National Health and Medical Research Council scoring.
Applications for the 2019 round of scholarships are now open.
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.